These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
170 related articles for article (PubMed ID: 37760902)
1. Thromboelastometry-Guided Individualized Fibrinolytic Treatment for COVID-19-Associated Severe Coagulopathy Complicated by Portal Vein Thrombosis: A Case Report. Forgács R; Bokrétás GP; Monori Z; Molnár Z; Ruszkai Z Biomedicines; 2023 Sep; 11(9):. PubMed ID: 37760902 [TBL] [Abstract][Full Text] [Related]
2. Point-of-care diagnosis and monitoring of fibrinolysis resistance in the critically ill: results from a feasibility study. Coupland LA; Rabbolini DJ; Schoenecker JG; Crispin PJ; Miller JJ; Ghent T; Medcalf RL; Aneman AE Crit Care; 2023 Feb; 27(1):55. PubMed ID: 36765421 [TBL] [Abstract][Full Text] [Related]
3. Suppression of Fibrinolysis and Hypercoagulability, Severity of Hypoxemia, and Mortality in COVID-19 Patients: A Retrospective Cohort Study. Corey KM; Olson LB; Naqvi IA; Morrison SA; Davis C; Nimjee SM; Que LG; Bachelder RE; Kraft BD; Chen L; Nair SK; Levy JH; Sullenger BA Anesthesiology; 2022 Jul; 137(1):67-78. PubMed ID: 35412597 [TBL] [Abstract][Full Text] [Related]
4. Impaired fibrinolysis in critically ill COVID-19 patients. Bachler M; Bösch J; Stürzel DP; Hell T; Giebl A; Ströhle M; Klein SJ; Schäfer V; Lehner GF; Joannidis M; Thomé C; Fries D Br J Anaesth; 2021 Mar; 126(3):590-598. PubMed ID: 33422287 [TBL] [Abstract][Full Text] [Related]
5. Fibrinolysis Shutdown Correlation with Thromboembolic Events in Severe COVID-19 Infection. Wright FL; Vogler TO; Moore EE; Moore HB; Wohlauer MV; Urban S; Nydam TL; Moore PK; McIntyre RC J Am Coll Surg; 2020 Aug; 231(2):193-203.e1. PubMed ID: 32422349 [TBL] [Abstract][Full Text] [Related]
6. Fibrin Strands Will Grow from Soluble Fibrin and Hang Up in an In Vitro Microcirculatory Viscoelastic Model: Is This a Major Cause of COVID-19 Associated Coagulopathy? Bull BS; Hay KL; Herrmann PC J Clin Med; 2022 Apr; 11(8):. PubMed ID: 35456177 [TBL] [Abstract][Full Text] [Related]
7. Severe SARS-CoV-2 Infection Inhibits Fibrinolysis Leading to Changes in Viscoelastic Properties of Blood Clot: A Descriptive Study of Fibrinolysis in COVID-19. Hammer S; Häberle H; Schlensak C; Bitzer M; Malek NP; Handgretinger R; Lang P; Hörber S; Peter A; Martus P; Mirakaj V; Gawaz M; Geisler T; Althaus K; Rosenberger P; Bakchoul T Thromb Haemost; 2021 Nov; 121(11):1417-1426. PubMed ID: 33634444 [TBL] [Abstract][Full Text] [Related]
8. Serial EXTEM, FIBTEM, and tPA Rotational Thromboelastometry Observations in the Maastricht Intensive Care COVID Cohort-Persistence of Hypercoagulability and Hypofibrinolysis Despite Anticoagulation. Hulshof AM; Brüggemann RAG; Mulder MMG; van de Berg TW; Sels JEM; Olie RH; Spaetgens B; Streng AS; Verhezen P; van der Horst ICC; Ten Cate H; Spronk HMH; van Bussel BCT; Henskens YMC Front Cardiovasc Med; 2021; 8():654174. PubMed ID: 33981736 [No Abstract] [Full Text] [Related]
9. Predictive ability of viscoelastic testing using ClotPro® for short-term outcome in patients with severe Covid-19 ARDS with or without ECMO therapy: a retrospective study. Heubner L; Greiner M; Vicent O; Beyer-Westendorf J; Tiebel O; Scholz U; Güldner A; Mirus M; Fries D; Koch T; Spieth PM Thromb J; 2022 Aug; 20(1):48. PubMed ID: 36038895 [TBL] [Abstract][Full Text] [Related]
10. Viscoelastometric Testing to Assess Hemostasis of COVID-19: A Systematic Review. Bareille M; Hardy M; Douxfils J; Roullet S; Lasne D; Levy JH; Stépanian A; Susen S; Frère C; Lecompte T; Mullier F J Clin Med; 2021 Apr; 10(8):. PubMed ID: 33923851 [TBL] [Abstract][Full Text] [Related]
11. High D dimers and low global fibrinolysis coexist in COVID19 patients: what is going on in there? Ibañez C; Perdomo J; Calvo A; Ferrando C; Reverter JC; Tassies D; Blasi A J Thromb Thrombolysis; 2021 Feb; 51(2):308-312. PubMed ID: 32671609 [TBL] [Abstract][Full Text] [Related]
12. Role of Thromboelastography and Thromboelastometry in Predicting Risk of Hypercoagulability and Thrombosis in Critically Ill COVID-19 Patients: A Qualitative Systematic Review. Tejpal Karna S; Singh P; Ahmad Haq Z; Jain G; Khurana A; Saigal S; Prakash Sharma J; Waindeskar V Turk J Anaesthesiol Reanim; 2022 Oct; 50(5):332-339. PubMed ID: 36301281 [TBL] [Abstract][Full Text] [Related]
13. Portal vein thrombosis after laparoscopic sleeve gastrectomy: presentation and management. Belnap L; Rodgers GM; Cottam D; Zaveri H; Drury C; Surve A Surg Obes Relat Dis; 2016 Dec; 12(10):1787-1794. PubMed ID: 27178606 [TBL] [Abstract][Full Text] [Related]
14. Fibrinolysis Shutdown and Thrombosis in a COVID-19 ICU. Creel-Bulos C; Auld SC; Caridi-Scheible M; Barker NA; Friend S; Gaddh M; Kempton CL; Maier CL; Nahab F; Sniecinski R Shock; 2021 Mar; 55(3):316-320. PubMed ID: 32769822 [TBL] [Abstract][Full Text] [Related]
15. Acute fibrinolysis shutdown occurs early in septic shock and is associated with increased morbidity and mortality: results of an observational pilot study. Schmitt FCF; Manolov V; Morgenstern J; Fleming T; Heitmeier S; Uhle F; Al-Saeedi M; Hackert T; Bruckner T; Schöchl H; Weigand MA; Hofer S; Brenner T Ann Intensive Care; 2019 Jan; 9(1):19. PubMed ID: 30701381 [TBL] [Abstract][Full Text] [Related]
16. COVID-19: coagulation disorders and anticoagulant treatment in patients hospitalised in ICU. Pluta J; Cieniewicz A; Trzebicki J Anaesthesiol Intensive Ther; 2021; 53(2):153-161. PubMed ID: 34006056 [TBL] [Abstract][Full Text] [Related]